NCT06654037
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06654037
Title Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care RECRUITING Irvine California 92612 United States Details
UC Irvine Health/Chao Family Comprehensive Cancer Center RECRUITING Orange California 92868 United States Details
Montefiore Medical Center-Einstein Campus RECRUITING The Bronx New York 10461 United States Details
Montefiore Medical Center-Weiler Hospital RECRUITING The Bronx New York 10461 United States Details
Montefiore Medical Center - Moses Campus RECRUITING The Bronx New York 10467 United States Details
University of Cincinnati Cancer Center-UC Medical Center RECRUITING Cincinnati Ohio 45219 United States Details
University of Cincinnati Cancer Center-West Chester RECRUITING West Chester Ohio 45069 United States Details
University of Pittsburgh Cancer Institute (UPCI) RECRUITING Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field